This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4cva
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==MPS1 kinase with 3-aminopyridin-2-one inhibitors== | ==MPS1 kinase with 3-aminopyridin-2-one inhibitors== | ||
| - | <StructureSection load='4cva' size='340' side='right' caption='[[4cva]], [[Resolution|resolution]] 2.50Å' scene=''> | + | <StructureSection load='4cva' size='340' side='right'caption='[[4cva]], [[Resolution|resolution]] 2.50Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4cva]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CVA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CVA FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4cva]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CVA OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CVA FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=WBI:N-(6-OXO-1,6-DIHYDRO-3,4-BIPYRIDIN-5-YL)-4-(PIPERIDIN-1-YL)BENZAMIDE'>WBI</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=WBI:N-(6-OXO-1,6-DIHYDRO-3,4-BIPYRIDIN-5-YL)-4-(PIPERIDIN-1-YL)BENZAMIDE'>WBI</scene></td></tr> | ||
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene></td></tr> | ||
| Line 17: | Line 17: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Dual-specificity kinase]] | [[Category: Dual-specificity kinase]] | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Bavetsias, V]] | [[Category: Bavetsias, V]] | ||
[[Category: Bayliss, R]] | [[Category: Bayliss, R]] | ||
Revision as of 09:16, 20 March 2019
MPS1 kinase with 3-aminopyridin-2-one inhibitors
| |||||||||||
